Ucommune closes second tranche of preferred sale

Ucommune International Ltd completed the second tranche of a preferred equity financing, issuing 2,250 Series A Convertible Preferred Shares to a single investor under a securities purchase agreement dated December 23, 2025.

Accepted by SEC EDGAR 02/13/2026 - 08:00 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Ucommune International Ltd completed the second tranche of a preferred equity financing, issuing 2,250 Series A Convertible Preferred Shares to a single investor under a securities purchase agreement dated December 23, 2025. Each preferred share was sold at a purchase price of US$1,000.00.

The Series A Convertible Preferred Shares are convertible into the Company’s Class A ordinary shares, par value US$0.024 per share, in accordance with a Certificate of Designations. The transaction is described as informational only and explicitly does not constitute an offer or solicitation to buy or sell securities.

Insights

Capital markets analyst

Ucommune raises capital via a second tranche of convertible preferred shares, adding funding with potential future equity dilution.

Ucommune International Ltd completed a second tranche of its Series A Convertible Preferred Shares issuance to a single investor, at a fixed price of US$1,000.00 per share. This reflects continued use of structured equity financing under a previously signed securities purchase agreement dated December 23, 2025.

The preferred shares are convertible into Class A ordinary shares based on terms in the Certificate of Designations. The eventual impact on ordinary shareholders depends on future conversion activity and timing, which are governed by those terms. Further detail on conversion mechanics and investor protections resides in the referenced exhibits and prior filings.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What financing transaction did Ucommune International Ltd (UK) report in this 6-K?

Ucommune reported closing the second tranche of a preferred share issuance. The company issued 2,250 Series A Convertible Preferred Shares to a single investor under a December 23, 2025 securities purchase agreement, continuing a structured equity financing arrangement.

How many Series A Convertible Preferred Shares did Ucommune (UK) issue and at what price?

Ucommune issued 2,250 Series A Convertible Preferred Shares at US$1,000.00 each. These shares were sold to an investor identified in the securities purchase agreement, reflecting a follow-on tranche under that previously executed financing deal.

Into what securities are Ucommune’s Series A Convertible Preferred Shares convertible?

The Series A Convertible Preferred Shares are convertible into Class A ordinary shares. Conversion terms are governed by a Certificate of Designations, which specifies how the preferred shares convert into Class A ordinary shares with a par value of US$0.024 per share.

When was the securities purchase agreement for Ucommune’s preferred shares signed?

The securities purchase agreement was dated December 23, 2025. The second tranche issuance reported here on February 12, 2026, took place pursuant to that agreement between Ucommune International Ltd and the identified investor.

Does this Ucommune (UK) 6-K constitute an offer to sell securities?

No, the report explicitly states it is not an offer or solicitation. The company clarifies that there will be no sale of these securities where such activity would be unlawful, emphasizing the informational nature of this disclosure.

What risks does Ucommune highlight alongside this preferred share update?

Ucommune includes broad forward-looking statement cautions. It cites uncertainties around growth strategies, competition in China’s office space market, regulatory policies in the PRC, and general economic conditions in China and globally, directing readers to its SEC filings for more detail.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of February 2026

Commission file number: 001-39738

Ucommune International Ltd

No. 2 Dongsihuan North Road, Building 1, 4th Floor

Chaoyang District, Beijing 100016

People’s Republic of China

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

Ucommune International Ltd Closes Second Tranche of Preferred Shares Issuance

On February 12, 2026, pursuant to that certain securities purchase agreement (the “Securities Purchase Agreement”) with an investor named therein (the “Buyer”) dated December 23, 2025, Ucommune International Ltd (“we,” “Ucommune” or the “Company”) (NASDAQ: UK), a co-working spaces and related service provider in China, issued a total of 2,250 Series A Convertible Preferred Shares (the “Preferred Shares”) to the Buyer at the purchase price of US$1,000.00 per Preferred Share (the “Preferred Shares Issuance”) and closed the second tranche of the Preferred Shares Issuance. The terms of the Preferred Shares are set forth in the certificate of designations, (the “Certificate of Designations”) and the Preferred Shares are convertible into Class A ordinary shares of the Company, par value $0.024 per share, in accordance with the terms of the Certificate of Designations.

The form of the Certificate of Designations and the Securities Purchase Agreement were included as Exhibit 4.1 and Exhibit 10.1 of the Company’s Current Report on Form 6-K filed on December 29, 2025.

This Form 6-K is for informational purposes only and is not an offer to sell or a solicitation of an offer to buy any securities. There will be no sale of these securities in any jurisdiction in which such an offer, solicitation of an offer to buy or sale would be unlawful.

Forward-looking Statements

This current report contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “potential,” “continue,” “ongoing,” “targets,” “guidance” and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Any statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company’s growth strategies; its future business development, results of operations and financial condition; its ability to understand members’ needs and provide products and services to attract and retain members; its ability to maintain and enhance the recognition and reputation of its brand; its ability to maintain and improve quality control policies and measures; its ability to establish and maintain relationships with members and business partners; trends and competition in China’s office space market; changes in its revenues and certain cost or expense items; the expected growth of China’s office space market; PRC governmental policies and regulations relating to the Company’s business and industry, and general economic and business conditions in China and globally and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this current report and in the attachments is as of the date of this current report, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Ucommune International Ltd
	/s/ Zirui Wang
	Name:	Zirui Wang
	Title:	Chief Executive Officer and Chief Risk Officer

Date: February 13, 2026

2